We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

15 hedge funds and large institutions have $34.7M invested in Minerva Neurosciences in 2015 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

176% more capital invested

Capital invested by funds: $12.6M → $34.7M (+$22.1M)

50% more funds holding

Funds holding: 10 → 15 (+5)

Holders
15
Holders Change
+5
Holders Change %
+50%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
2
Closed
1
Calls
$608M
Puts
–
Net Calls
+$608M
Net Calls Change
+$608M

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$12.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$6.55M
3
CAM
Cormorant Asset Management
Massachusetts
+$5.02M
4
PA
Perceptive Advisors
New York
+$4.2M
5
AC
Armistice Capital
New York
+$1.05M

Top Sellers

Rank Fund Capital Flow
1
CCA
Catalyst Capital Advisors
New York
-$1.78M
2
TRCT
Tower Research Capital (TRC)
New York
-$5.8K
3
Goldman Sachs
Goldman Sachs
New York
-$662

NERV Hedge Fund Activity: Q1 2015 in Review

15 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q1 2015, worth a combined $34.7M — up 176% from $12.6M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NERV positions and 1 closed out — a net gain of 5 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Federated Hermes, adding an estimated $12.8M. The largest seller was Catalyst Capital Advisors, exiting entirely with an estimated $1.78M sold.

  • 15 institutional investors held Minerva Neurosciences (NERV) as of Q1 2015, up from 10 in Q4 2014.
  • Funds reported $34.7M of Minerva Neurosciences stock for Q1 2015, up 176% quarter-over-quarter.
  • 6 funds opened new Minerva Neurosciences positions in Q1 2015 and 1 closed out, a net change of +5 holders.
  • The largest Minerva Neurosciences buyer in Q1 2015 was Federated Hermes, an estimated $12.8M added.
  • The largest Minerva Neurosciences seller in Q1 2015 was Catalyst Capital Advisors, an estimated $1.78M sold.

Based on aggregated 13F filings for Q1 2015.